CryoPort (CYRX) Competitors $9.68 +0.32 (+3.42%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$9.72 +0.04 (+0.37%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYRX vs. VERA, SRPT, APGE, NTLA, HROW, AUPH, IMCR, EWTX, TWST, and COGTShould you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Vera Therapeutics (VERA), Sarepta Therapeutics (SRPT), Apogee Therapeutics (APGE), Intellia Therapeutics (NTLA), Harrow (HROW), Aurinia Pharmaceuticals (AUPH), Immunocore (IMCR), Edgewise Therapeutics (EWTX), Twist Bioscience (TWST), and Cogent Biosciences (COGT). These companies are all part of the "pharmaceutical products" industry. CryoPort vs. Its Competitors Vera Therapeutics Sarepta Therapeutics Apogee Therapeutics Intellia Therapeutics Harrow Aurinia Pharmaceuticals Immunocore Edgewise Therapeutics Twist Bioscience Cogent Biosciences Vera Therapeutics (NASDAQ:VERA) and CryoPort (NASDAQ:CYRX) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations. Is VERA or CYRX more profitable? CryoPort has a net margin of 37.21% compared to Vera Therapeutics' net margin of 0.00%. CryoPort's return on equity of -9.79% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vera TherapeuticsN/A -46.70% -39.46% CryoPort 37.21%-9.79%-5.42% Which has more volatility and risk, VERA or CYRX? Vera Therapeutics has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500. Do institutionals and insiders believe in VERA or CYRX? 99.2% of Vera Therapeutics shares are held by institutional investors. Comparatively, 92.9% of CryoPort shares are held by institutional investors. 16.3% of Vera Therapeutics shares are held by company insiders. Comparatively, 10.1% of CryoPort shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to VERA or CYRX? In the previous week, Vera Therapeutics had 2 more articles in the media than CryoPort. MarketBeat recorded 4 mentions for Vera Therapeutics and 2 mentions for CryoPort. Vera Therapeutics' average media sentiment score of 1.39 beat CryoPort's score of 0.51 indicating that Vera Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vera Therapeutics 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CryoPort 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend VERA or CYRX? Vera Therapeutics presently has a consensus price target of $63.00, suggesting a potential upside of 109.02%. CryoPort has a consensus price target of $12.56, suggesting a potential upside of 29.71%. Given Vera Therapeutics' higher possible upside, research analysts plainly believe Vera Therapeutics is more favorable than CryoPort.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vera Therapeutics 1 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.60CryoPort 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.82 Which has higher valuation & earnings, VERA or CYRX? CryoPort has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVera TherapeuticsN/AN/A-$152.15M-$3.58-8.42CryoPort$228.38M2.12-$114.76M$1.337.28 SummaryCryoPort beats Vera Therapeutics on 11 of the 16 factors compared between the two stocks. Get CryoPort News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoPortTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$484.68M$5.53B$7.29B$10.54BDividend YieldN/A2.53%940.02%4.70%P/E Ratio7.2810.7215.1326.71Price / Sales2.121.16604.31202.98Price / CashN/A10.847.9431.09Price / Book1.303.002.476.57Net Income-$114.76M$188.93M$558.45M$276.78M7 Day Performance2.87%-1.36%0.38%1.96%1 Month Performance-6.47%-0.19%6.03%9.11%1 Year Performance22.69%-10.04%3.75%31.60% CryoPort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoPort3.95 of 5 stars$9.68+3.4%$12.56+29.7%+22.7%$484.68M$228.38M7.281,186Positive NewsVERAVera Therapeutics2.7274 of 5 stars$28.90+2.5%$63.00+118.0%-26.2%$1.80BN/A-8.0740Positive NewsSRPTSarepta Therapeutics4.5982 of 5 stars$18.82+2.5%$39.32+108.9%-81.2%$1.79B$1.90B-21.631,372APGEApogee Therapeutics3.1207 of 5 stars$39.83+4.2%$92.63+132.6%-26.8%$1.76BN/A-9.6491Insider TradeNTLAIntellia Therapeutics4.3692 of 5 stars$16.92+3.7%$27.39+61.9%+11.0%$1.75B$57.88M-3.61600Gap UpHROWHarrow2.969 of 5 stars$48.40+2.8%$67.83+40.2%-9.8%$1.74B$199.61M-193.60180Trending NewsAnalyst RevisionAUPHAurinia Pharmaceuticals3.1184 of 5 stars$11.06-15.8%$13.00+17.5%+59.4%$1.73B$235.13M25.72300High Trading VolumeIMCRImmunocore2.5531 of 5 stars$34.34+0.9%$56.89+65.7%+10.0%$1.71B$310.20M-85.85320Positive NewsEWTXEdgewise Therapeutics2.7775 of 5 stars$15.75-1.9%$38.83+146.6%-44.9%$1.69BN/A-10.1660Gap UpTWSTTwist Bioscience3.7006 of 5 stars$27.00+0.3%$49.40+83.0%-28.3%$1.62B$312.97M-18.62990COGTCogent Biosciences2.6491 of 5 stars$14.13-0.2%$20.00+41.5%+41.9%$1.61BN/A-7.9480 Related Companies and Tools Related Companies Vera Therapeutics Competitors Sarepta Therapeutics Competitors Apogee Therapeutics Competitors Intellia Therapeutics Competitors Harrow Competitors Aurinia Pharmaceuticals Competitors Immunocore Competitors Edgewise Therapeutics Competitors Twist Bioscience Competitors Cogent Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYRX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoPort, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoPort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
